No association of catastrophic events with Advair

American Journal of Medicine

Volumn 123, Issue 10, 2010, Pages

  Yancey, Steven W ^a   Knobil, Katharine ^a   Kral, Kenneth ^a  

^a GLAXOSMITHKLINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; FLUTICASONE PROPIONATE PLUS SALMETEROL; PLACEBO; SALMETEROL; ANDROSTANE DERIVATIVE; ANTIASTHMATIC AGENT; DRUG COMBINATION; FLUTICASONE, SALMETEROL DRUG COMBINATION; SALBUTAMOL;

ASTHMA; CLINICAL TRIAL; HUMAN; INTUBATION; LETTER; PRIORITY JOURNAL; RISK ASSESSMENT; ANALOGS AND DERIVATIVES; CHEMICALLY INDUCED; DRUG COMBINATION; DRUG INTERACTION; INHALATIONAL DRUG ADMINISTRATION;

ADMINISTRATION, INHALATION; ADRENERGIC BETA-AGONISTS; ALBUTEROL; ANDROSTADIENES; ANTI-ASTHMATIC AGENTS; ASTHMA; DRUG COMBINATIONS; DRUG INTERACTIONS; HUMANS;

EID: 77957758134     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2010.03.029     Document Type: Letter

References (5)

1. S.R. Salpeter, A.J. Wall, and N.S. Buckley Long-acting beta-agonists with and without inhaled corticosteroids and catastrophic asthma events Am J Med 123 2010 322 328 e2. Epub 2010 Feb 20
2. GlaxoSmithKline Briefing Information http://www.fda.gov/ohrms/dockets/ac/ 08/briefing/2008-4398b1-04-GSK.pdf Accessed July 7, 2010
3. R. Jaeschke, P.M. O'Byrne, and F. Mejza The safety of long-acting β-agonists among patients with asthma using inhaled corticosteroids: systematic review and metaanalysis Am J Respir Crit Care Med 178 2008 1009 1016
4. M. Weatherall, M. Wijesinghe, and K. Perrin Meta-analysis of the risk of mortality with salmeterol and the effect of concomitant inhaled corticosteroid therapy Thorax 65 2010 39 43
5. E. Bateman, H. Nelson, and J. Bousquet Meta-analysis: effects of adding salmeterol to inhaled corticosteroids on serious asthma-related events Ann Intern Med 149 2008 33 42